Aitia is excited to announce its participation in the upcoming AD/PD™ 2023, a global conference on Alzheimer’s and Parkinson’s Diseases, to be held in Gothenburg, Sweden from March 28 – April 1.If you are interested in learning more about Aitia’s latest breakthroughs, particularly in the field of Alzheimer’s disease, we encourage you to schedule a meeting with our team. We are excited to share our recent discovery of a new target that serves as a driver of TAU-related outcomes in both virtual patients and brain models. Contact us today to schedule a meeting and discover how our innovative approach to drug target identification can benefit your research.